Royal Sense Limited · CashKonnect

About

Royal Sense Limited engages in supplying various surgical accessories, tools, equipment, and other pharmaceutical products under the STERGIC brand name. It offers medical equipment, surgical instruments and consumables, laboratory equipment and reagents, medical consumables, diagnostics tools, sanitary products, pharmaceuticals, medicine, and cosmetics, as well as disposables. The company serves hospitals, laboratories, institutions, and clinics. Royal Sense Limited was founded in 2015 and is based in New Delhi, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in — check back soon.

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Sep 2023
Sales	37.75	27.64	18.96	8.03
Expenses	32.93	23.39	16.59	7.09
Operating Profit	4.82	4.25	2.37	0.94
OPM %	12.77	15.38	12.50	11.71
Other Income	0.09	0.08	0.03	0.01
Interest	0.80	0.18	0.09	0.00
Depreciation	0.05	0.02	0.01	0.00
Profit before tax	4.06	4.13	2.30	0.95
Tax %	25.62	26.15	26.09	26.32
Net Profit	3.01	3.04	1.70	0.70
EPS in Rs	5.63	6.12	3.47	2.03
Dividend Payout %	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024
Equity Capital	5.35	4.97	4.90
Reserves	27.83	19.60	13.44
Borrowings	8.98	3.26	1.60
Other Liabilities	3.95	3.02	0.94
Total Liabilities	46.11	30.85	20.88
Fixed Assets	1.82	1.65	0.05
CWIP	0.00	0.00	0.00
Investments	4.43	0.44	0.43
Other Assets	39.86	28.76	20.40
Total Assets	46.11	30.85	20.88

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2025	Mar 2024
Cash from Operating Activity	1.80	-0.79
Cash from Investing Activity	-11.07	-4.55
Cash from Financing Activity	2.89	13.10
Net Cash Flow	-6.39	7.77
Free Cash Flow	0.18	-0.82
CFO/OP %	58.00	-33.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024
Debtor Days	149.29	117.79	90.48
Inventory Days	106.73	53.66	6.27
Days Payable	2.95	22.43	0.46
Cash Conversion Cycle	253.07	149.02	96.29
Working Capital Days	142.13	100.63	118.78
ROCE %	13.89	18.04	—